Nicotine metabolism principally requires put while in the liver. Thus, when nicotine is administered from the GI process, it undergoes to start with-go metabolism by the liver, bringing about a bioavailability of only about twenty%. This process inherently decreases the bioavailability of nicotine within the procedure and may lead to adverse GI con